Shortages of “supportive care” drugs, for chemotherapy-induced nausea or to protect the kidneys, can delay cancer treatments, said Yoram Unguru, a pediatric oncologist & bioethicist at Sinai and the Johns Hopkins Berman Institute of Bioethics. When he gets the hospital’s list of shortages, “I scream, I shout, I shake my head”

Quick Read

This Pharma Exec Is Accused Of Fixing Prices On 107 Drugs

Quick Read

More than 40 states say the biggest drug makers engaged in “industry-wide conspiracy” to fix prices of generic drugs

Quick Read

In Indiana, a local hospital system, Parkview Health, charged private insurance companies about quadruple what the federal Medicare program paid for the same care, according to a study of hospital prices in 25 states released on Thursday by the nonprofit RAND Corp

Quick Read

Novartis AG is expected to begin selling Zolgensma, a possible cure for spinal muscular atrophy, after the FDA approves it this month. Novartis executives say Zolgensma’s ability to curb SMA—a muscle-wasting disease that often kills babies before age 2—explains the eye-popping price

Quick Read

Summer Bummer

April 30, 2019

The snake struck a 9-year-old hiker at dusk on a nature trail. The outrageous bills struck her parents a few weeks later

Quick Read

Bob Field was set to kick off his second course of BCG — a potent immunotherapy that treats his fast-growing bladder cancer. Instead, the New York City banking executive got a call from his urologist’s office, canceling that week’s appointment

Quick Read

Big pharma is partnering with influencers to sell new drugs and medical devices

Quick Read